Literature DB >> 28811697

Role of Iron and Copper in the Pathogenesis of Parkinson's Disease.

Mohit Kumar Gangania1, Jyoti Batra1, Suman Kushwaha2, Rachna Agarwal3.   

Abstract

Parkinson's disease (PD) is an old age disorder of basal ganglia which involves oligomerization of α-synuclein protein and formation of intercellular inclusions known as "Lewy bodies" in substantia nigra and caudate nuclei in brain which is progressive in nature. It is second most prevalent neurodegenerative disorder characterized by tremor at rest, muscle rigidity, slowness of movement (bradykinesia, akinesia), and changes in posture (instability). Both excess and deficiency in levels of transition metals (especially iron, copper) can be detrimental to the central nervous system. Abnormalities in iron (Fe) and copper (Cu) metabolism have been reported to produce oxidative stress which is one of the major cause in pathogenesis of PD. In the present study 35 PD patients and 33 controls of Northern Indian population were included and serum levels of Fe, Cu and ceruloplasmin (Cp) were measured. Serum Fe (p < 0.01) and Cu (p < 0.01) levels were found to be significantly decreased in PD, whereas there was no significant change in Cp levels in PD patients as compared to controls. These results suggest the existence of a defect in iron which over the time, may hasten the entry of iron into the brain and decrease iron in the extracellular compartment in PD patients.

Entities:  

Keywords:  Ceruloplasmin; Copper; Iron; Oxidative stress; Parkinson’s disease

Year:  2016        PMID: 28811697      PMCID: PMC5539009          DOI: 10.1007/s12291-016-0614-5

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  17 in total

1.  Clinical utility of copper, ceruloplasmin, and metallothionein plasma determinations in human neurodegenerative patients and their first-degree relatives.

Authors:  Nathalie Arnal; Diana Olga Cristalli; María J T de Alaniz; Carlos Alberto Marra
Journal:  Brain Res       Date:  2009-12-22       Impact factor: 3.252

2.  Metal-triggered structural transformations, aggregation, and fibrillation of human alpha-synuclein. A possible molecular NK between Parkinson's disease and heavy metal exposure.

Authors:  V N Uversky; J Li; A L Fink
Journal:  J Biol Chem       Date:  2001-09-11       Impact factor: 5.157

3.  Decreased serum ceruloplasmin levels characteristically aggravate nigral iron deposition in Parkinson's disease.

Authors:  Lirong Jin; Jian Wang; Lei Zhao; Hang Jin; Guoqiang Fei; Yuwen Zhang; Mengsu Zeng; Chunjiu Zhong
Journal:  Brain       Date:  2010-11-24       Impact factor: 13.501

Review 4.  The Haber-Weiss reaction and mechanisms of toxicity.

Authors:  J P Kehrer
Journal:  Toxicology       Date:  2000-08-14       Impact factor: 4.221

5.  Copper, ceruloplasmin, superoxide dismutase and iron parameters in Parkinson's disease.

Authors:  G Tórsdóttir; J Kristinsson; S Sveinbjörnsdóttir; J Snaedal; T Jóhannesson
Journal:  Pharmacol Toxicol       Date:  1999-11

6.  Serum trace element levels and the complexity of inter-element relations in patients with Parkinson's disease.

Authors:  Muralidhar L Hegde; Ponnuswamy Shanmugavelu; Bhuma Vengamma; T S Sathyanarayana Rao; Rani B Menon; Ranganath V Rao; K S Jagannatha Rao
Journal:  J Trace Elem Med Biol       Date:  2004       Impact factor: 3.849

7.  Cerebrospinal fluid levels of transition metals in patients with Parkinson's disease.

Authors:  F J Jiménez-Jiménez; J A Molina; M V Aguilar; I Meseguer; C J Mateos-Vega; M J González-Muñoz; F de Bustos; A Martínez-Salio; M Ortí-Pareja; M Zurdo; M C Martínez-Para
Journal:  J Neural Transm (Vienna)       Date:  1998       Impact factor: 3.575

Review 8.  Novel chelators for central nervous system disorders that involve alterations in the metabolism of iron and other metal ions.

Authors:  Des R Richardson
Journal:  Ann N Y Acad Sci       Date:  2004-03       Impact factor: 5.691

Review 9.  The relevance of iron in the pathogenesis of Parkinson's disease.

Authors:  Mario E Götz; Kay Double; Manfred Gerlach; Moussa B H Youdim; Peter Riederer
Journal:  Ann N Y Acad Sci       Date:  2004-03       Impact factor: 5.691

10.  Serum iron levels and the risk of Parkinson disease: a Mendelian randomization study.

Authors:  Irene Pichler; Fabiola Del Greco M; Martin Gögele; Christina M Lill; Lars Bertram; Chuong B Do; Nicholas Eriksson; Tatiana Foroud; Richard H Myers; Michael Nalls; Margaux F Keller; Beben Benyamin; John B Whitfield; Peter P Pramstaller; Andrew A Hicks; John R Thompson; Cosetta Minelli
Journal:  PLoS Med       Date:  2013-06-04       Impact factor: 11.069

View more
  4 in total

1.  Interdependence of metals and its binding proteins in Parkinson's disease for diagnosis.

Authors:  Athira Anirudhan; Paramasivam Prabu; Jaya Sanyal; Tapas Kumar Banerjee; Gautam Guha; Ram Murugesan; Shiek S S J Ahmed
Journal:  NPJ Parkinsons Dis       Date:  2021-01-04

2.  Platinum-Based Interdigitated Micro-Electrode Arrays for Reagent-Free Detection of Copper.

Authors:  Robert Daly; Tarun Narayan; Han Shao; Alan O'Riordan; Pierre Lovera
Journal:  Sensors (Basel)       Date:  2021-05-19       Impact factor: 3.576

Review 3.  Oxidative Stress in Parkinson's Disease: Potential Benefits of Antioxidant Supplementation.

Authors:  Sandro Percário; Aline da Silva Barbosa; Everton Luiz Pompeu Varela; Antônio Rafael Quadros Gomes; Michelli Erica Souza Ferreira; Thayana de Nazaré Araújo Moreira; Maria Fani Dolabela
Journal:  Oxid Med Cell Longev       Date:  2020-10-12       Impact factor: 6.543

4.  The Role of Iron Metabolism in Fatigue, Depression, and Quality of Life in Multiple Sclerosis Patients.

Authors:  Anna Knyszyńska; Aleksandra Radecka; Paulina Zabielska; Joanna Łuczak; Beata Karakiewicz; Anna Lubkowska
Journal:  Int J Environ Res Public Health       Date:  2020-09-18       Impact factor: 3.390

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.